Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Onconetix ( (ONCO) ) has issued an announcement.
On February 12, 2025, Onconetix, Inc. issued a promissory note to Keystone Capital Partners with a principal amount of $117,647.06, due by November 12, 2025, subordinate to existing debts. This note may require earlier payment if additional capital is raised. Additionally, on February 18, 2025, Christian Brühlmann resigned as Chief Strategy Officer but will continue as Chief Business Officer at Proteomedix AG.
More about Onconetix
YTD Price Performance: -17.05%
Average Trading Volume: 9,276,696
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.86M
Learn more about ONCO stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue